PTPI Bathi mangsa ngarep Petros Pharmaceuticals Inc

Simbol resmi perusahaan Petros Pharmaceuticals Inc (PTPI)

Petros Pharmaceuticals delegates production and logistics to external partners while adhering to strict FDA medical regulations regarding biomaterial disposal. The expected final financial result on GURU.Markets reflects the consensus trend, where the metric serves as the target level. Petros Pharmaceuticals is scaling sales of Stendra and developing digital IT platforms, aiming for long-term expansion through B2B networks to strengthen its market position.

petrospharma.com (PTPI): Bathi resik sing dikarepake saka 04.07.2022 nganti 18.11.2026

Petros - rincian analitis lan metrik utama (PTPI)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:PTPI, Petros Pharmaceuticals, Inc.
Produk dadi Petros Pharmaceuticals Inc

This indicator assesses the potential of Petros Pharmaceuticals (PTPI) through the lens of daily operating income. The analysis of profit expectations is based on projected cash flow calculations, reflecting the issuer's current phase in the technological cycle. The upward curve confirms the effective commercialization of urological drugs. Diversifying distribution through digital pharmacies reduces reliance on government contracts, thereby stabilizing the metric. It is critical for investors to distinguish fundamental leadership from market overheating.

Analisis pesaing Petros Pharmaceuticals

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Bathi resik sing dikarepake|PRGO: Bathi mangsa ngarep|Alvotech SA - Bathi resik mangsa ngarep|LQDA: Proyeksi bathi mangsa ngarep|Galapagos Genomics - Penghasilan resik sing dikarepake|ANIP (ANI Pharmaceuticals Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake mannkindcorp.com MNKD|Bathi sing dikarepake Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SPRY (ARS Pharmaceuticals Inc)|Bathi resik mangsa ngarep TBPH (Theravance)|AQST - Bathi sing dikarepake|scPharmaceuticals (SCPH) - Bathi mangsa ngarep|TECX: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik TNXP|Bathi sing dikarepake China SXT Pharmaceuticals, Inc.|EPRX: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep BHST|EXOZ - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ORMP (oramed.com)|Proyeksi bathi mangsa ngarep enterabio.com ENTX|HYFT - Bathi sing dikarepake|Prakiraan bathi perusahaan ABVC BioPharma, Inc ABVC|CPIX: Proyeksi bathi mangsa ngarep|Quantum BioPharma Ltd - Penghasilan resik sing dikarepake|Bathi mangsa ngarep FGEN|Telomir Pharmaceuticals, Inc. - Bathi forward|Proyeksi bathi mangsa ngarep RANI|SNYR (Synergy CHC) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Rallybio RLYB|Lexaria Bioscience (LEXX) - Bathi resik sing dikarepake|PULM - Bathi sing dikarepake|Prakiraan bathi perusahaan Pheton Holdings PTHL|APM (Aptorum) - Bathi mangsa ngarep|Lyra Therapeutics, Inc. (LYRA) - Proyeksi bathi mangsa ngarep|IBO (impactbiomedinc.com) - Proyeksi bathi mangsa ngarep|TNFA (TNF Pharmaceuticals) - Bathi resik mangsa ngarep|Bathi sing dikarepake cbdmd.com (YCBD)|Prakiraan bathi perusahaan PainReform Ltd|Proyeksi bathi mangsa ngarep CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Bathi resik sing dikarepake|OPTN - Bathi sing dikarepake|Pieris Pharmaceuticals - Bathi resik mangsa ngarep|PROC (Procaps Group) - Bathi mangsa ngarep|Qilian International Holding Group (QLI) - Proyeksi bathi mangsa ngarep|SLRN (ACELYRIN, Inc.) - Proyeksi bathi mangsa ngarep|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan